| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 88.060 | 962.320 | 1.234.172 | 328.112 | 622.018 | 1.049.071 | 1.248.155 | 1.885.466 |
| Total Income - EUR | - | 0 | 93.723 | 986.310 | 1.251.836 | 339.266 | 649.987 | 1.050.336 | 1.248.653 | 1.914.137 |
| Total Expenses - EUR | - | 131 | 105.149 | 700.900 | 1.064.137 | 615.092 | 645.952 | 875.860 | 1.048.828 | 1.379.448 |
| Gross Profit/Loss - EUR | - | -131 | -11.426 | 285.409 | 187.699 | -275.826 | 4.036 | 174.477 | 199.825 | 534.689 |
| Net Profit/Loss - EUR | - | -131 | -15.027 | 277.711 | 168.891 | -275.826 | 4.036 | 167.195 | 191.932 | 458.729 |
| Employees | - | 0 | 6 | 19 | 22 | 0 | 17 | 10 | 12 | 14 |
Check the financial reports for the company - Eastern Biologix Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 1.441 | 26.491 | 38.830 | 32.583 | 25.122 | 18.662 | 15.543 | 336.440 | 348.461 |
| Current Assets | - | 7.115 | 64.183 | 282.867 | 215.203 | 48.532 | 91.179 | 482.770 | 212.586 | 627.801 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 6.572 | 43.274 | 138.653 | 135.667 | 45.182 | 66.488 | 469.578 | 196.991 | 585.212 |
| Cash | - | 544 | 20.908 | 144.214 | 79.536 | 3.350 | 24.690 | 13.192 | 15.595 | 42.589 |
| Shareholders Funds | - | 2.096 | -12.966 | 264.983 | 171.419 | -452.397 | -438.329 | 15.487 | 207.372 | 626.952 |
| Social Capital | - | 2.227 | 2.189 | 2.149 | 2.107 | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | - | 6.460 | 104.197 | 56.714 | 97.125 | 526.052 | 548.169 | 482.826 | 340.456 | 348.514 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.199 | 795 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Eastern Biologix Srl